LEADER 01245nam--2200397---450- 001 990002137970203316 005 20090522142334.0 035 $a000213797 035 $aUSA01000213797 035 $a(ALEPH)000213797USA01 035 $a000213797 100 $a20041103d1974----km-y0itay0103----ba 101 0 $aeng 102 $aUS 105 $a||||||||001yy 200 1 $aControlling drugs$einternational handbook for psychoactive drug classification$fRichard H. Blum, Daniel Bovet, James Moore 210 $aSan Francisco$cJossey-Bass$d1974 215 $aXXII, 378 p.$d26 cm 410 0$12001 454 1$12001 461 1$1001-------$12001 676 $a613.9 702 1$aMOORE,$bJames 702 1$aBOVET,$bDaniel 702 1$aBLUM,$bRichard H. 801 0$aIT$bsalbc$gISBD 912 $a990002137970203316 951 $a613.9 Con 1a (IML B 11 625)$b40171 E.C.$c613.9 Con 1a (IML B 11)$d00172569 951 $a613.9 Con 1 (IML B 11 614)$b40834 E.C.$c613.9 Con 1 (IML B 11)$d00172568 959 $aBK 969 $aECO 979 $aSIAV6$b10$c20041103$lUSA01$h1910 979 $aRSIAV1$b90$c20090522$lUSA01$h1422 979 $aRSIAV1$b90$c20090522$lUSA01$h1423 996 $aControlling drugs$91039532 997 $aUNISA LEADER 03198nam 22005415 450 001 9910349449903321 005 20200705192731.0 010 $a3-030-21859-7 024 7 $a10.1007/978-3-030-21859-1 035 $a(CKB)4100000008959065 035 $a(MiAaPQ)EBC5849817 035 $a(DE-He213)978-3-030-21859-1 035 $a(PPN)260303135 035 $a(EXLCZ)994100000008959065 100 $a20190810d2019 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aInfections in Neutropenic Cancer Patients /$fedited by Ana Paula Velez, Jorge Lamarche, John N. Greene 205 $a1st ed. 2019. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2019. 215 $a1 online resource (187 pages) 311 $a3-030-21858-9 327 $aCentral Nervous System Infections in Neutropenic Cancer Patients -- Head and Neck Infections.-Respiratory Infections -- Gastrointestinal and Genitourinary Infections -- Skin Infections.-Bacteremia in Neutropenic Patients -- Fungal Infections -- Neutropenic Fever -- Antifungal Medications in Neutropenia -- Antimicrobial Prophylaxis -- Antimicrobial Stewardship in Immunocompromised Host -- Index. 330 $aAs bone marrow transplant treatments and chemotherapy develop, the population of neutropenic cancer patients is on the rise. These developments are allowing patients to live longer, but in recent years, they have also led to an increase in previously rare infections and syndromes, whose management is unfamiliar to the average healthcare professional. Infections in Neutropenic Cancer Patients is a crucial resource for medical students, residents, practitioners, health professionals, and researchers. It details the clinical presentation, diagnoses, and management of an array of common infections and syndromes specific to neutropenic cancer patients, including real scenarios accompanied by color photos and radiographic results. Chapters include step-by-step tutorials, access to clinical answers on diagnosis and treatment, and a tabulated summary of the key points. 606 $aCancer research 606 $aInfectious diseases 606 $aAntibodies 606 $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001 606 $aInfectious Diseases$3https://scigraph.springernature.com/ontologies/product-market-codes/H33096 606 $aAntibodies$3https://scigraph.springernature.com/ontologies/product-market-codes/B14010 615 0$aCancer research. 615 0$aInfectious diseases. 615 0$aAntibodies. 615 14$aCancer Research. 615 24$aInfectious Diseases. 615 24$aAntibodies. 676 $a616.994 676 $a616.9 702 $aVelez$b Ana Paula$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aLamarche$b Jorge$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aGreene$b John N$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910349449903321 996 $aInfections in Neutropenic Cancer Patients$91994006 997 $aUNINA